Shanghai Ruikang Biotechnology R&D Co., Ltd. announced that it will receive CNY 100 million in a round of funding on March 31, 2023. The transaction will include participation from returning investor Yili Chuannig Biotechnology Co., Ltd. The transaction has been approved by the 23rd meeting of the first board of directors and the 18th meeting of the first board of supervisors. After the capital increase, the registered capital of the company will increase from CNY 200 million to CNY 300 million.